Bristol-Myers Squibb Company
NYSE: BMY
$54.20
Closing Price on October 3, 2024
BMY Articles
24/7 Insights The stock market is overbought and may be ready for a correction. Stifel’s Barry Bannister has called massive market moves in the past. Access 2 legendary, high-yield dividend stocks...
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions...
Published:
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and...
Published:
With the first quarter half over and the major indices higher for 2024, many investors think a significant correction could be coming. After a tremendous 2023 and the solid start to this year, the...
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
Published:
2022 was a dreadful year for investors, with the S&P 500 down almost 20% and the Nasdaq lower by a stunning 33%. What a difference a year can make. In 2023, the S&P 500 was up 24.2 %, with...
Published:
Another acquisition for Bristol Myers, another acquisition offer from Nano Dimension, and Apple's Watch woes.
Published:
The Johnson brothers started Johnson & Johnson in 1886 JHVEPhoto / iStock Editorial via Getty Images The iconic healthcare giant was started by Robert, James, and Edward Johnson in 1886 after...
Published:
The last trading day before the Christmas holiday has stocks headed for a mixed opening following a good, not great, inflation report.
Published:
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
Published:
2023 has been a much better year than 2022, as all major indices are higher. The tech-heavy Nasdaq is up a whopping 32.5%, while the venerable S&P 500 is up 15.36% and the Dow Jones Industrial...
Published:
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Published: